Literature DB >> 27034456

Introduction: Autoimmunity Special Issue.

Kazuhiko Yamamoto.   

Abstract

Mesh：

Year:  2016        PMID： 27034456      PMCID： PMC4889887          DOI： 10.1093/intimm/dxw010

Source DB:  PubMed          Journal:  Int Immunol        ISSN： 0953-8178            Impact factor:   4.823


× No keyword cloud information.
  6 in total

Review 1.  Genetics of autoimmune diseases: perspectives from genome-wide association studies.

Authors:  Yuta Kochi
Journal:  Int Immunol       Date:  2016-02-08       Impact factor: 4.823

Review 2.  CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.

Authors:  Kiyoshi Hirahara; Toshinori Nakayama
Journal:  Int Immunol       Date:  2016-02-12       Impact factor: 4.823

Review 3.  T follicular helper cells, T follicular regulatory cells and autoimmunity.

Authors:  Yangyang Zhu; Le Zou; Yun-Cai Liu
Journal:  Int Immunol       Date:  2015-12-29       Impact factor: 4.823

Review 4.  Therapeutic potential of regulatory cytokines that target B cells.

Authors:  Keishi Fujio; Tomohisa Okamura; Shuji Sumitomo; Kazuhiko Yamamoto
Journal:  Int Immunol       Date:  2015-12-08       Impact factor: 4.823

5.  Leptin deficiency down-regulates IL-23 production in glomerular podocytes resulting in an attenuated immune response in nephrotoxic serum nephritis.

Authors:  Kei Goto; Yoshikatsu Kaneko; Yuya Sato; Tadashi Otsuka; Suguru Yamamoto; Shin Goto; Keiko Yamamoto; Tadashi Yamamoto; Hiroshi Kawachi; Michael P Madaio; Ichiei Narita
Journal:  Int Immunol       Date:  2015-11-13       Impact factor: 4.823

Review 6.  Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases.

Authors:  Yuping Lai; Chen Dong
Journal:  Int Immunol       Date:  2015-11-06       Impact factor: 4.823
  6 in total
  2 in total

Review 1.  Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?

Authors:  Muhammad Sadeqi Nezhad; Alexander Seifalian; Nader Bagheri; Sajad Yaghoubi; Mohammad Hossein Karimi; Meghdad Adbollahpour-Alitappeh
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561

Review 2.  Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases.

Authors:  Radha Krishan Shandil; Saumya Dhup; Shridhar Narayanan
Journal:  Stem Cells Int       Date:  2022-07-28       Impact factor: 5.131
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.